We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure (ERADICATE-HF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03416270
Recruitment Status : Unknown
Verified May 2018 by David Z.I. Cherney, University Health Network, Toronto.
Recruitment status was:  Not yet recruiting
First Posted : January 31, 2018
Last Update Posted : May 2, 2018
University Medical Center Groningen
Merck Sharp & Dohme LLC
University of Toronto
Toronto General Hospital
Information provided by (Responsible Party):
David Z.I. Cherney, University Health Network, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 1, 2021
Estimated Study Completion Date : March 1, 2021